COVID-19 y telepsiquiatría: un reto para el tratamiento de la salud mental

Introduction

Due to the COVID-19 pandemic, in-person psychiatric care decreased, but mental disorders, such as post-traumatic stress disorder, anxiety, depression, obsessive compulsive symptoms and insomnia increased. Our objective was to describe the usefulness, advantages, disadvantages and limitations of telemedicine used in psychiatric patients’ clinical care before and during the COVID-19 pandemic.

Methods

A critical search was carried out on platforms such as PubMed, Cochrane, Lilacs and academic Google, in addition to an in-depth assessment of all the primary studies that answer our questions.

Results

Telepsychiatry is a tool that can help resolve the need for psychiatric care in a more comprehensive way. Advantages include cost reduction, enabling care provision to rural areas, the fact that its effectiveness is comparable to in-person care and its use is suitable in a variety of scenarios, and also that it helps reduce stigma and enables continuous training processes among medical staff. In the context of the current pandemic, it reduces the risk of transmission by maintaining biosecurity measures. However, there are also limitations in its use, such as the collection of medical insurance payments, mandatory in-person visits for examinations or procedures, difficulty in developing a doctor-patient relationship, and uncertainty about how to give informed consent and maintain the patient's privacy. Additionally, there is the difficulty in controlling the patient's environment, with the risk of the consultation taking place somewhere inappropriate, and the fact that there are certain populations which would not benefit from the use of telepsychiatry and areas where its use is made difficult by a greater digital gap. Based on these advantages and disadvantages, recommendations can be made when considering telepsychiatry as a medical care option.